Oppenheimer Maintains Outperform on Amdocs, Raises Price Target to $109
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Timothy Horan maintains an Outperform rating on Amdocs (NASDAQ:DOX) and raises the price target from $99 to $109.
August 04, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer maintains an Outperform rating on Amdocs and raises the price target from $99 to $109, indicating a positive outlook for the company.
The raised price target by Oppenheimer indicates a positive outlook for Amdocs. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100